GlaxoSmithKline (GSK) has begun the sale of some of its consumer health brands, hoping to raise around £1 billion before spinning off its consumer healthcare business with Pfizer, according to ...
With the launch of Polident, which is the global market leader in the denture care, the company has reinforced its presence in the overall oral health category in India, GSK Consumer Healthcare ...
GlaxoSmithKline has announced its second major deal this month, signing an agreement with Pfizer to combine its consumer health business and form a joint venture with combined annual sales of $12. ...
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...
After twelve months of pandemic and lockdowns, brands are taking stock of the past year and making decisions on where to go next. Twelve months on from the first lockdowns in the west, brands and ...
11d
Zacks Investment Research on MSNGSK Stock Recovers, Rises Around 17% YTD: Time to Buy, Sell or Hold?GSK GSK stock has risen 16.9% year to date compared with an increase of 7.0% for the industry. The stock has also ...
As one of the largest pharmaceutical and vaccine companies, GSK has used its vast resources to create the next generation of healthcare treatments. The company's innovative new product lineup and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results